advertisement

WGA Rescources

11.1 General management, indication (9)

Showing records 1 to 9

Display all abstracts in classification 11.1 General management, indication

Search within classification 11.1 General management, indication
15248 Topical ocular hypotensive medication and lens opacification: evidence from the ocular hypertension treatment study
Herman DC; Gordon MO; Beiser JA; Chylack LT Jr; Lamping KA; Schein OD; Soltau JB; Kass MA; Ocular Hypertension Treatment Study (OHTS) Group
American Journal of Ophthalmology 2006; 142: 800-810
14954 Glaucoma medications: use and safety in the elderly population
Kanner E; Tsai JC
Drugs and Aging 2006; 23: 321-332
14657 Current status of medication for glaucoma in a university hospital
Kokuzawa S; Kondo Y; Yamamoto T
Japanese Journal of Clinical Ophthalmology 2006; 60: 1679-1684
14445 Improvement in glaucomatous visual field thresholds after reduction of intraocular pressure: Clinical vs. surgical treatment
Magacho L; Queiroz CF; Medeiros M; Lima FE; Magacho B; Avila M
Arquivos Brasileiros de Oftalmologia 2006; 69: 51-55
15082 Failure of medical therapy despite normal intraocular pressure
Walland MJ; Carassa RG; Goldberg I; Grehn F; Heuer DK; Khaw PT; Thomas R; Parikh R
Clinical and Experimental Ophthalmology 2006; 34: 827-836
15284 Changes in glaucoma treatment and achieved IOP after introduction of new glaucoma medication
van der Valk R; Schouten JS; Webers CA; Hendrikse F; Prins MH
Graefe's Archive for Clinical and Experimental Ophthalmology 2006; 244: 1267-1272
14950 Adjunctive glaucoma therapy use associated with travoprost, bimatoprost, and latanoprost
Covert D; Robin AL
Current Medical Research and Opinion 2006; 22: 971-976
15014 Relationship between compliance and background factors of glaucoma patients
Ikushima T; Mori K; Ishibashi T; Ikeda Y; Naruse S; Hozono Y; Kinoshita S
Nippon Ganka Gakkai Zasshi 2006; 110: 497-503
15218 Effect of medical therapy on glaucoma filtration surgery rates in Ontario
Rachmiel R; Trope GE; Chipman ML; Gouws P; Buys YM
Archives of Ophthalmology 2006; 124: 1472-1477

Issue 8-4

Change Issue


advertisement

Oculus